Diet therapy in the treatment of neuropediatric disorders;Dietas médicas en el tratamiento de las enfermedades neuropediátricas

Revista de Neurologia

Volumn 37, Issue 3, 2003, Pages 267-274

  Chaves Carballo, E ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Adrenoleukodystrophy; Attention deficit disorders; Diet; Inborn errors of metabolism; Ketogenic diet; Refractory epilepsy

Indexed keywords

FOOD DYE; LONG CHAIN FATTY ACID; LORENZO OIL; VITAMIN;

ADRENOLEUKODYSTROPHY; AMINO ACID COMPOSITION; ATTENTION DEFICIT DISORDER; CONFERENCE PAPER; DIET SUPPLEMENTATION; DIET THERAPY; FOOD COMPOSITION; HUMAN; INBORN ERROR OF METABOLISM; INTRACTABLE EPILEPSY; KETOGENESIS; OUTCOMES RESEARCH; PROTEIN RESTRICTION; VITAMIN SUPPLEMENTATION;

EID: 0141920753     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3703.2003142     Document Type: Conference Paper

References (50)

1. Tojo R. Tratado de nutrición pediátrica. Barcelona: SORPAMA; 2001.
2. Mahan LK, Escott-Stump S. Nutrición y dietoterapia, de Krause. 10 ed. México: McGraw-Hill Interamericana; 2001.
3. Chaves-Carballo E. Manifestaciones clínicas de los trastornos peroxisomales. Rev Neurol 1998; 27: 296-300.
4. Girós M, Ruiz M, Ribes A, Pàmpols T. Diagnóstico de las enfermedades peroxisomales en España en el período 1987-1997. Rev Neurol 1999; 28 (Supl 1): S40-4.
5. Al-Essa MA, Sakati NA, Bakheet SM, Patay ZJ, Dabbagh O, Chaves-Carballo E, et al. X-linked adrenoleukodystrophy. The Saudi experience. Saudi Med J 2000; 21: 61-70.
6. Moser H. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 1998; 120: 1485-508.
7. Moser AB, Kreiter N, Bezman L, Lu S, GV, Naidu S, et al. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann Neurol 1999; 45: 100-10.
8. Rizzo WB, Watkins PA, Phillips MW, Cranin D, Campbell B, Avigan J. Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids. Neurology 1986; 36: 357-61.
9. Moser AB, Borel J, Odone A, Naidu S, Comblath D, Sanders DB, et al. A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients. Ann Neurol 1987; 21: 240-9.
10. Van Geel BM, Assies J, Haverkort EB, Koelman JHTM, Verbeeten Jr B, Wanders RJA, et al. Progression of abnormalities in adrenomyelo-neuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with 'Lorenzo's oil'. J Neurol Neurosurg Psychiatr 1999; 67: 290-9.
11. Aubourg P, Adamsbaum C, Lavallard-Rousseau MC, Rocchiccioli F, Carter N, Jambaque I, et al. A two-year trial of oleic and erucic acids ('Lorenzo's oil') as treatment for adrenomyeloneuropathy. N Engl J Med 1993; 329: 745-52.
12. Poulos A, Gibson R, Sharp P, Beckman K, Grattan-Smith P. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil. Ann Neurol 1994; 36: 741-6.
13. Rasmussen M, Moser AB, Borel K, Khangoora S, Moser HW. Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's oil). Neurochem Res 1994; 19: 1073-82.
14. Ríos VG, Panico LR, Demartini MG, Camiello MA. Complicaciones en el tratamiento para la epilepsia con dieta cetogénica. Rev Neurol 2001; 33: 909-15.
15. Pour RB, Stockler-Ipsiroglu S, Hunneman DH, Gahr M, Korenke GC, Pabst W, et al. Enhanced lymphocyte proliferation in patients with adrenoleukodystrophy treated with erucic acid (22:1)-rich triglycerides. J Inherit Metab Dis 2000; 23: 113-9.
16. Tuchman RF. Tratamiento del trastorno por déficit de atención con hiperactividad. Rev Neurol 2001; 33: 210-5.
17. Feingold B. Hyperkinesis and learning disabilities linked to artificial food flavors and colors. Am J Nurs 1975; 75: 797-803.
18. Wender EH, Lipton MA. The National Advisory Committee report on hyperkinesis and food additives -Final report to the Nutrition Foundation. Washington, DC: The Nutrition Foundation; 1980.
19. Mattes JA, Gittelman R. Effects of artificial food coloring in children with hyperactive symptoms. A critical review and results of a controlled study. Arch Gen Psychiatry 1981; 38: 714-8.
20. Rowe KS, Rowe KJ. Synthetic food coloring and behavior: a dose response effect in a double-blind, placebo-controlled, repeated-measures study. J Pediatr 1994; 125: 691-8.
21. Wolraich ML, Lindgren SD, Stumbo PJ, Stegink LD, Appelbaum MI, Kiristy MC. Effects of diets high in sucrose or aspartame on the behavior and cognitive performance of children. N Engl J Med 1994; 330: 301-7.
22. Sánchez-Álvarez JC, Serrano-Castro PJ, Cañ adillas-Hidalgo F. Epilepsia refractaria del adulto. Rev Neurol 2002; 35: 931-53.
23. Zubillaga P. Epilepsia. In Tojo R, ed. Tratado de nutrición pediátrica. Barcelona: SORPAMA; 2001. p. 972.
24. Geyelin HR. Fasting as a method for treating epilepsy. Medical Record 1921; 99: 1038-9.
25. Wilder RM. The effects of ketonemia on the course of epilepsy. Mayo Clin Bull 1921; 2: 307-14.
26. Keith HM. Convulsive disorders in children. With reference to treatment with ketogenic diet. Boston: Little Brown & Co; 1963.
27. Livingston S. Dietary management of epilepsy. In Livingston S, ed. Comprehensive management of epilepsy in infancy, childhood and adolescence. Springfield, IL: Charles C. Thomas; 1972. p. 378-405.
28. Kinsman SL, Vining EPG, Quaskey SA, Mellitis D, Freeman JM. Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases. Epilepsia 1992; 33: 1132-6.
29. Freeman JM, Vining EPG, Pillas DJ, Pyzik PL, Casey JC, Kelly MT. The efficacy of the ketogenic diet 1998: a prospective evaluation of intervention in 150 children. Pediatrics 1998; 102: 1358-63.
30. Casey JC, McGrogan J, Pillas D, Pyzik P, Freeman J, Vining EP. The implementation and maintenance of the ketogenic diet in children. J Neurosci Nurs 1999; 31: 294-302.
31. Caraballo R, Tripoli J, Escobal L, Cersósimo R, Tenenbaum S, Palacios C, et al. Dieta cetogénica: eficacia y tolerabilidad en epilepsia refractaria en pediatría. Rev Neurol 1998; 26: 61-4.
32. Panico LR, Demartini MG, Ríos VG, Carniello MA. Dieta cetogénica en la epilepsia refractaria infantil: respuesta electroclínica, complicaciones y efectos secundarios. Rev Neurol 2000; 31: 212-20.
33. Freeman JM. The epilepsy diet treatment. An introduction to the ketogenic diet. New York: Demos Publications; 1994.
34. Forcadas-Berdusán MI. Indicaciones y resultados de los tratamientos no farmacológicos de las epilepsias: estimulación vagal, dieta cetogénica y rayos gamma. Rev Neurol 2002; 35 (Supl 1): S144-50.
35. Huttenlocher PR, Wilboum AJ, Signore TM. Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology 1971; 21: 1097-103.
36. Galván-Manso M, Arellano M, Sans A, Sanmarti FX, Gómez L, Vernet A, et al. Dieta cetogénica: ¿una alternativa válida en epilepsias refractarias? Rev Neurol 2001; 33: 1010-4.
37. Acosta PB, Yannicelli S. The Ross metabolic formula system. Nutrition support protocols. 4 ed. Columbus, OH: Ross Products Division/Abbott Laboratories; 2001.
38. Maydell BV, Wyllie E, Akhtar N, Kotagal P, Powaski K, Cook K, et al. Efficacy of the ketogenic diet in focal versus generalized seizures. Pediatr Neurol 2001; 25: 208-12.
39. Coppola G, Veggiotti P, Cusmai R, Bertoli S, Cardinali S, Dionisi-Vici C, et al. The ketogenic diet in children, adolescents and young adults with refractory epilepsy: an Italian multicentric experience. Epilepsy Res 2002; 48: 221-7.
40. Earl R, Borra ST. Lineamientos para la planificación alimentaria. In Mahan LK, Escott-Stump S, eds. Nutrición y dietoterapia, de Krause. 10 ed. México: McGraw-Hill Interamericana; 2001. p. 366.
41. Vining EP. Clinical efficacy of the ketogenic diet. Epilepsy Res 1999; 37: 181-90.
42. Kaytal NG, Koehler AN, McGhee B, Foley CM, Crumrine PK. The ketogenic diet in refractory epilepsy: the experience of Children's Hospital of Pittsburgh. Clin Pediatr (Phila) 2000; 39: 153-9.
43. Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: a systematic review of efficacy. Pediatrics 2000; 105: 46.
44. Best TH, Franz DN, Gilbert DL, Nelson DP, Epstein MR. Cardiac complications in pediatric patients on the ketogenic diet. Neurology 2000; 54: 2328-30.
45. Chaves-Carballo E, al-Essa MA. Encefalopatías de origen genético en el recién nacido. Rev Neurol 1999; 29: 231-8.
46. Al-Essa MA, Ozand PT. Manual of metabolic diseases. Riyadh: King Faisal Specialist Hospital & Research Centre; 1998.
47. Chamoles N. Errores congénitos del metabolismo: urgencias metabólicas y errores congénitos del metabolismo. In Fejerman N, Fernández-Álvarez E, eds. Neurología pediátrica. 2 ed. Buenos Aires: Médica Panamericana; 1997. p. 301-7.
48. Rashed MS, Bucknall MP, Little D, Awad A, Jacob M, Almoudi M, et al. Screening blood spots for inborn errors of metabolism by electro-spray tandem mass spectrometry with a microplate batch process and a computer algorithm for automated flagging of abnormal profiles. Clin Chem 1997; 43: 1129-41.
49. Scriver CR, Beaudet AL, Sly WS, Valle D. The metabolic and molecular bases of inherited disease. 7 ed. New York: McGraw-Hill; 1995.
50. Trahms CM. Nutrioterapia médica en trastomos metabólicos. In Mahan LK, Escott-Stump S, eds. Nutrición y dietoterapia, de Krause. 10 ed. México: McGraw-Hill Interamericana; 2001. p. 1065-88.